Binit Shah, MD, shares how our new multidisciplinary clinic can improve your patients' quality of life.
Author: Megan Davis
We strive to be your trusted resource when your patients need cardiothoracic surgical care by offering a strong team with diverse expertise.
Researchers are building on groundbreaking work published in 2019 that set the standard for treating patients who fail first-line therapy.
Research on how spreading depolarizations cause secondary injury in early recovery could be the tip of the iceberg in finding new treatments for a range of brain-related conditions.
UVA Health is among the first in the U.S. to offer BiTE therapy to small cell lung cancer patients in the outpatient setting.
Learn how this therapy can offer a critical second-line option for your stage 4 small cell lung cancer patients.
Targeting the transcription factors that drive certain cancers could lead to more effective, less toxic treatments.
Recent analysis from the SHINE trial has found a link between high blood sugar after thrombolysis and life-threatening brain bleeds, especially in patients with severe strokes.
Researchers believe understanding mutations in ER protein translocation and processing complexes will lead to improved treatments for patients with congenital disorders of glycosylation.
UVA Health's Pituitary Tumor Program ensures optimal patient outcomes through collaboration, cutting-edge techniques, and streamlined care pathways.